Related Experiment Video

Updated: Jun 6, 2026

Ole Isacson: Development of New Therapies for Parkinson's Disease
23:53

Ole Isacson: Development of New Therapies for Parkinson's Disease

Published on: April 29, 2007

Discovering neuroprotection in Parkinson's disease, or getting to haphazard

Karl Kieburtz1

  • 1University of Rochester Medical Center, Rochester, NY, USA. karl.kieburtz@ctcc.rochester.edu

The Mount Sinai Journal of Medicine, New York
|November 25, 2010
PubMed

Insights

Finding a Parkinson's disease therapy to slow progression requires integrating basic science, clinical research, and medical practice observations. Rigorous clinical trials are essential to confirm any promising neuroprotective insights.

Area of Science:

  • Neuroscience
  • Neurology
  • Clinical Research

Background:

  • Parkinson's disease (PD) neuroprotection remains a significant unmet clinical need.
  • Current therapeutic strategies primarily manage symptoms rather than halting disease progression.

Discussion:

  • A multi-faceted approach is crucial for discovering effective neuroprotective therapies for Parkinson's.
  • Integrating basic science, clinical research, and real-world medical practice observations is vital.

Key Insights:

  • No single perspective guarantees success in developing neuroprotective treatments.
  • Confirmation through rigorous clinical trial testing is indispensable for validating potential insights.

Outlook:

  • A combined, integrated strategy offers the most promising pathway toward a Parkinson's neuroprotective therapy.
  • Future research should focus on synergistic integration of diverse scientific and clinical data.

Related Concept Videos

Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.